TPIV mov is ahead
TPIV200
Triple-negative breast cancer (TNBC) - second line
3Q 2018
09/30/2018
Phase 2 interim response data due 3Q 2018.
Triple-negative breast cancer (TNBC) - second line
3Q 2018
09/30/2018
Phase 2 interim response data due 3Q 2018.
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。